Slide 1: Fourth Quarter/Full Year 2017 Financial Results and Business Highlights
Fourth Quarter/ Full Year 2017 Financial Results and Business Highlights March 20, 2018
Slide 2: Forward-looking statements
Forward-looking statements “Safe Harbor” s tatement under the Private Securities Litigation Reform Act of 1995: This presentation c ontains forward-looking s tatements about the company and its products, including s tatements relating to c omponents of the company’s long-term financial success;;
Slide 3: Successful results in 2017 set the stage for expanded growth in 2018
Successful results in 2017 set the stage for expanded growth in 2018 2017 focused on path to profitability and shift in strategy • Sharpened focus on non-GM wheat nutrition traits and commercial launch strategy • Continued to advance commercialization of agricultural productivity traits through reg
Slide 4: Arcadia addresses today's challenges in the food and agriculture value chain
Arcadia addresses today’s challenges in the food and agriculture value chain Challenge #1 Challenge #2 Consumers demand healthy, high quality, Food manufacturers demand reliable s upply, natural and s ustainable food products versatile and economically viable raw materials Food Consumers manufacture
Slide 5: Introducing GoodWheat ingredient brand!
Introducing GoodWheatTM ingredient brand! GoodWheat brand includes: • High fiber Resistant Starch wheat • Extended Shelf Life wheat • Reduced Gluten wheat • Future wheat innovations Delivers distinct market differentiation for consumer food companies to provide specialty products to discerning consu
Slide 6: Path to Commercialization of RS wheat
Path to Commercialization of RS wheat Achieved key technical milestones • 94% amylose, compared to 25%-30% in traditional wheat • High fiber levels that meet FDA requirements for “high in fiber” and ”good source of fiber” designations Breeding into commercial germplasm • Planting increased acres of
Slide 7: Ag Productivity traits continue to advance through field trials and regulatory progress
Ag Productivity traits continue to advance through field trials and regulatory progress HB4 Drought Tolerant soybeans • Second year of commercial germplasm trials are underway • Drought conditions in Argentina are ideal for testing trait • FDA approval in 2017, regulatory studies for submission for
Slide 8: Revenue
Revenue Fourth Quarter Full year Favorable/ (Unfavorable) Favorable/ (Unfavorable) 2017 2016 $ % 2017 2016 $ % Product revenue 32 247 (216) (87%) 514 669 (155) (23%) License revenue 1,117 (365) 1,483 405% 1,470 144 1,326 921% Contract research and 279 658 (379) (58%) 2,042 2,375 (333) (14%) governme
Slide 9: Operating expenses
Operating expenses Fourth Quarter Full Year Favorable/ (Unfavorable) Favorable/ (Unfavorable) 2017 2016 $ % 2017 2016 $ % Cost of product 20 653 633 97% 283 895 612 68% revenues R&D expense 2,166 1,990 (176) (9%) 7,407 8,663 1,256 15% SG&A expense 2,241 3,368 1,127 33% 10,651 12,250 1,599 13% Total
Slide 10: Key financial results
Key financial results Fourth Quarter Full Year Favorable/(Unfavorable) Favorable/(Unfavorable) 2017 2016 $ % 2017 2016 $ % Total revenues 1,428 540 888 165% 4,026 3,188 838 26% Cost of product revenues 20 653 633 97% 283 895 612 68% R&D expense 2,166 1,990 (176) (9%) 7,407 8,663 1,256 15% SG&A expen
Slide 11: Thank you!
®D Arcadia BIOS CIEN CE 8S